Hypoglycemia: Physician and Patient Perspectives

AstraZeneca

Status: Completed

Conditions: Hypoglycemia; Type 2 Diabetes Mellitus

Study type: Observational

Funder types: Industry

Identifiers

NCT01176656

NIS-CUS-DUM-2010/1

Details and patient eligibility

About

The purpose of this study is to assess the burden of hypoglycemia and identify unmet need related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on OADs and/or insulin. This is an observational study which will identify patients with T2DM in an administrative claims database and will link claims data with results of patient and physician surveys concerning hypoglycemia.

Enrollment: 800 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• T2DM claims diagnosis (algorithm-based) with at least 2 pharmacy claims for an antidiabetic drug
• at least 1 HbA1c test recorded during the identification period
• continuous enrollment in the health plan for at least 12 months prior to survey date

Exclusion criteria

• Type 1 Diabetes Mellitus
• pregnancy or gestational diabetes

Trial design

800 participants in 3 patient groups

SU

Description:

T2DM patients with a prescription for a sulfonylurea but no insulin

Antidiabetic without SU

Description:

T2DM patients with an oral antidiabetic drug other than an SU, and no insulin

Insulin

Description:

T2DM patients using insulin, with or without other oral antidiabetics